Calithera Biosciences, Inc.
CALA · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $60 | $107 | $60 |
| Short-Term Investments | $0 | $0 | $8 | $97 |
| Receivables | $0 | $0 | $2 | $0 |
| Inventory | $0 | $0 | $0 | -$0 |
| Other Curr. Assets | $1 | $2 | $2 | $2 |
| Total Curr. Assets | $27 | $61 | $119 | $160 |
| Property Plant & Equip (Net) | $2 | $3 | $6 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $3 | $7 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $29 | $65 | $126 | $169 |
| Liabilities | – | – | – | – |
| Payables | $1 | $4 | $2 | $2 |
| Short-Term Debt | $2 | $3 | $4 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $8 | $0 | $2 |
| Other Curr. Liab. | $5 | -$1 | $13 | $15 |
| Total Curr. Liab. | $7 | $14 | $18 | $20 |
| LT Debt | $0 | $42 | $5 | $7 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $42 | $5 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $7 | $8 |
| Total Liabilities | $8 | $56 | $23 | $26 |
| Equity | – | – | – | – |
| Pref Stock | $22 | $41 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$513 | -$491 | -$376 | -$286 |
| AOCI | $0 | -$41 | $0 | $0 |
| Other Equity | $511 | $500 | $479 | $428 |
| Total Equity | $20 | $8 | $102 | $142 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $29 | $65 | $126 | -$260 |
| Net Debt | -$24 | -$14 | -$99 | -$52 |